LOC90246: A Protein of Interest for Drug Targets Or Biomarkers

Target Name: LOC90246

NCBI ID: G90246

LOC90246

Other Name(s): Uncharacterized LOC90246 | uncharacterized LOC90246

LOC90246: A Protein of Interest for Drug Targets Or Biomarkers

LOC90246 is a protein that is expressed in various tissues throughout the body. It is a member of the LOC90246 family, which is characterized by the presence of a unique N-terminus and a specificity domain. LOC90246 is of interest as a potential drug target or biomarker due to its unique structure and the involvement of several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The LOC90246 protein is composed of 154 amino acid residues and has a calculated molecular mass of 19.9 kDa. It is expressed in a variety of tissues, including muscle, heart, brain, liver, and kidney. LOC90246 is also known to be expressed in various cancer types, including breast, ovarian, and colorectal cancer.

One of the key features of LOC90246 is its unique N-terminus. Unlike many other proteins, LOC90246 has a short N-terminus that is only 24 amino acids long. This shortness is unusual because it is typically the case that proteins with long N-terms are more stable and have better stability and function. However, the unique N-terminus of LOC90246 has been shown to play a critical role in its function and stability.

In addition to its unique N-terminus, LOC90246 is also notable for its involvement in several diseases. For example, LOC90246 has been shown to be involved in neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. This is due to the fact that LOC90246 is a protein that is involved in the formation of neurotransmitters, which are important for the functioning of nerve cells.

Another disease that is associated with LOC90246 is cancer. LOC90246 has been shown to be involved in the development and progression of several types of cancer, including breast, ovarian, and colorectal cancer. This is due to the fact that LOC90246 is a protein that is involved in the regulation of cell growth and division, which is important for the development and progression of cancer.

Finally, LOC90246 has also been shown to be involved in autoimmune disorders. This is due to the fact that LOC90246 is a protein that is involved in the regulation of immune responses, which is important in autoimmune disorders.

In conclusion, LOC90246 is a protein that is expressed in various tissues throughout the body and has been shown to be involved in several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique N-terminus and the involvement of several diseases make it an attractive potential drug target or biomarker. Further research is needed to fully understand the role of LOC90246 in these diseases and to develop effective treatments.

Protein Name: Uncharacterized LOC90246

The "LOC90246 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC90246 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets